China
Africa
Explore chapters and articles related to this topic
Psychotic Disorders and Co-occurring Substance Use Disorders
Published in Tricia L. Chandler, Fredrick Dombrowski, Tara G. Matthews, Co-occurring Mental Illness and Substance Use Disorders, 2022
Tricia L. Chandler, Fredrick Dombrowski
As with schizophrenia disorder, the main characteristics of positive symptoms and negative symptoms are present in those living with schizophreniform disorders. The frequency and duration of symptoms varies between these disorders. Those living with schizophreniform disorder show symptoms that have been present for a total duration of more than one month and less than six months. The time limit associated with this diagnosis indicates the expectance that symptoms would resolve within six months of their onset. In situations where symptoms remain after six months, the diagnosis is changed to schizophrenia disorder (pp. 96–97). This condition can be misdiagnosed if a patient is experiencing difficulty with memory recollection and may be a poor historian. The lack of information available to the assessing counselor may cause them to assume that the symptoms observed are relatively acute, although connection with collateral contacts and reading information about previous episodes of care may provide further clarity on differentiating between schizophrenia and schizophreniform disorders.
ENTRIES A–Z
Published in Philip Winn, Dictionary of Biological Psychology, 2003
A schizophreniform disorder can be characterized in exactly the same way as SCHIZOPHRENIA. What differentiates it from schizophrenia is its duration: a schizophreniform disorder is one that lasts only from one to six months, no longer. The term BRIEF PSYCHOTIC DISORDER is also used to describe this condition.
Topic 11 Consultation Liaison Psychiatry
Published in Melvyn W.B. Zhang, Cyrus S.H. Ho, Roger C.M. Ho, Basant K. Puri, Get Through, 2016
Melvyn W.B. Zhang, Cyrus S.H. Ho, Roger C.M. Ho, Basant K. Puri
Neuropsychiatric sequelae of head injury Post-concussion syndrome occurs in 50% of the patients after 2 months and 12% after 1 year.Depression and anxiety are common.Secondary mania occurs in 9% of the patients.Schizophreniform disorder occurs in 2.5% of the patients.Paranoid psychosis occurs in 2% of the patients.Psychotic depression occurs in 1% of the patients.Impulsive personality as a result of a decreased level of 5-Hydroxyindoleacetic acid (5-HIAA) after head injury.Dementia is usually non-progressive.Memory deficit is the most frequent chronic cognitive disturbance.Head injury in children is associated with restlessness, overactivity, disobedience and temper tantrums.Seizure occurs in 5% of head injury victims. If dura mater is penetrated, the risk of epilepsy is 30%.
Validation of the Italian version of the clinician affective reactivity index (CL-ARI)
Published in Nordic Journal of Psychiatry, 2023
Valerio Zaccaria, Susanna Maggi, Alessia Bof, Marco Tofani, Giovanni Galeoto, Ignazio Ardizzone
The research group recruited the participant sample during the period from April 2021 to February 2022 from inpatient and outpatient services of the Child Neuropsychiatry Unit of the Department of Human Neurosciences of Sapienza University of Rome. This convenience sample met the following inclusion criteria: (a) aged between 7 and 17 years, (b) having a diagnosis of Dysthymia/Depression Disorder (DD)/DMDD, anxiety disorders, (Attention Deficit/Hyperactivity Disorder (ADHD), Oppositional Defiant Disorder/Conduct Disorder (ODD/CD), any combination of them, or no diagnosis, according to the DSM-5 criteria. Diagnoses were assessed through a psychodiagnostic evaluation carried out by two independent mental health workers (child psychiatrists or psychologists) which administered tests and had interviews with children and their parents/caregivers. More than a diagnosis was possible. Exclusion criteria were: (a) diagnosis of schizophrenia, schizophreniform disorder, or schizoaffective illness, (b) diagnosis of pervasive developmental disorder, (c) an IQ below 70 as assessed by the Wechsler Intelligence Scale for Children 4th edition (WISC IV) [16]. Recruitment strategies included face-to-face meetings with children and families and the use of explicative brochures to explain the research study purposes and data management strategies. To estimate the sample size, we referred to the only validation study of the CL-ARI conducted on 98 children.
Efficacy and acceptability of three prolactin-sparing antipsychotics in patient with schizophrenia: a network meta-analysis
Published in Psychiatry and Clinical Psychopharmacology, 2019
Jianjie Huang, Min Chen, Ce Chen, Xiaodong Lin, Deguo Jiang, Yonghui Zhang, Lina Wang, Chuanjun Zhuo, Hongjun Tian, Chenyuan Du
Studies that met the inclusion criteria were included: (i) Patients: Schizophrenia, schizoaffective disorder, or schizophreniform disorder as defined by any diagnostic criteria. (ii) Intervention: Acute treatment (4–12 weeks) with one of three prolactin-sparing antipsychotics (15–30 mg/day of aripiprazole, 400–1,000 mg/day of quetiapine, and 120–200 mg/day of ziprasidone) [25] as monotherapies, including both flexible and fixed-dose studies. (iii) Comparator: Placebo or another agent of the five mentioned above. (iv) Outcomes: Primary outcomes were the mean change in the total score of the Positive and Negative Syndrome Scale (PANSS), Brief Psychiatric Rating Scale (BPRS), and Clinical Global Impressions-Severity (CGI-S) score from baseline to endpoint. The secondary outcome was acceptability (the proportion of patients who left the study early for any reason). (v) Study design: Randomized controlled trial (RCT).
Yoga versus Non-Standard Care for Schizophrenia
Published in Issues in Mental Health Nursing, 2018
The methods utilised in this review were consistent with the methods outlined in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins & Green, 2011). Searching for relevant trials was conducted in the Cochrane Schizophrenia Group’s Trails Register which is compiled by MEDLINE, PubMed, Embase, AMED, BIOSIS, CINAHL, PsycINFO, and registries of clinical trials and conducted up to March 30, 2017. The review included randomised and quasi-randomised clinical trials, people with a diagnosis of schizophrenia or related disorders, including schizophreniform disorder, schizoaffective disorder, and delusional disorder, regardless of their gender, age, or severity of illness, whose diagnosis was made by any means. The intervention included yoga as defined by the study, and included Mantra, Laya, Hatha and Raja, also breathing exercised and/or meditation and/or body postures were considered. Non-standard care included but was not limited to other forms of exercise, talking therapy, expressive therapies or a combination of any or all. Short term, medium term and long-term outcomes were considered.